{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:29:07Z","timestamp":1786400947305,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08314"],"award-info":[{"award-number":["21K08314"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11756"],"award-info":[{"award-number":["24K11756"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11596"],"award-info":[{"award-number":["25K11596"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22J22286"],"award-info":[{"award-number":["22J22286"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K19458"],"award-info":[{"award-number":["25K19458"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02772"],"award-info":[{"award-number":["21H02772"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008529","name":"Chiba University","doi-asserted-by":"publisher","award":["IFCU-2022-05"],"award-info":[{"award-number":["IFCU-2022-05"]}],"id":[{"id":"10.13039\/501100008529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP256f0137008"],"award-info":[{"award-number":["JP256f0137008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ama221528"],"award-info":[{"award-number":["JP23ama221528"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ck0106055s"],"award-info":[{"award-number":["JP25ck0106055s"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ck0106001s"],"award-info":[{"award-number":["JP25ck0106001s"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The SGH Foundation"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011746","name":"NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011746","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chiba prefecture Research Grant,"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.1038\/s41388-026-03894-7","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:52:44Z","timestamp":1783695164000},"page":"3401-3412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A truncated TNS3 isoform expressed in metastatic triple negative breast cancer stabilizes FAK and promotes lung metastasis"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0305-7008","authenticated-orcid":false,"given":"Takao","family":"Morinaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-3033","authenticated-orcid":false,"given":"Shouko","family":"Hayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushige","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikiya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4146-3629","authenticated-orcid":false,"given":"Masahito","family":"Kawazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3894_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress. npj Breast Cancer. 2022;8:95.","journal-title":"npj Breast Cancer"},{"key":"3894_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.clbc.2024.06.001","volume":"24","author":"B Vuong","year":"2024","unstructured":"Vuong B, Jacinto AI, Chang SB, Kuehner GE, Savitz AC. Contemporary review of the management and treatment of young breast cancer patients. Clin Breast Cancer. 2024;24:663\u201375.","journal-title":"Clin Breast Cancer"},{"key":"3894_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91\u2013113.","journal-title":"Nat Rev Clin Oncol"},{"key":"3894_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10549-015-3479-z","volume":"152","author":"S Loibl","year":"2015","unstructured":"Loibl S, Jackisch C, Lederer B, Untch M, Paepke S, Kummel S, et al. Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials. Breast Cancer Res Treat. 2015;152:377\u201387.","journal-title":"Breast Cancer Res Treat"},{"key":"3894_CR5","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429\u201334.","journal-title":"Clin Cancer Res"},{"key":"3894_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/XCS.0000000000000714","volume":"237","author":"B Vuong","year":"2023","unstructured":"Vuong B, Darbinian J, Savitz A, Odele P, Perry LM, Sandhu L, et al. Breast cancer recurrence by subtype in a diverse, contemporary cohort of young women. J Am College Surg. 2023;237:13\u201323.","journal-title":"J Am College Surg"},{"key":"3894_CR7","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.1245\/s10434-021-10227-3","volume":"28","author":"M Taskindoust","year":"2021","unstructured":"Taskindoust M, Thomas SM, Sammons SL, Fayanju OM, DiLalla G, Hwang ES, et al. Survival outcomes among patients with metastatic breast cancer: review of 47,000 patients. Ann Surg Oncol. 2021;28:7441\u20139.","journal-title":"Ann Surg Oncol"},{"key":"3894_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","volume":"87","author":"M Castaneda","year":"2022","unstructured":"Castaneda M, den Hollander P, Kuburich NA, Rosen JM, Mani SA. Mechanisms of cancer metastasis. Semin Cancer Biol. 2022;87:17\u201331.","journal-title":"Semin Cancer Biol"},{"key":"3894_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","volume":"22","author":"DVF Tauriello","year":"2022","unstructured":"Tauriello DVF, Sancho E, Batlle E. Overcoming TGFbeta-mediated immune evasion in cancer. Nat Rev Cancer. 2022;22:25\u201344.","journal-title":"Nat Rev Cancer"},{"key":"3894_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-00436-9","volume":"6","author":"S Liu","year":"2021","unstructured":"Liu S, Ren J, Ten Dijke P. Targeting TGFbeta signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6:8.","journal-title":"Signal Transduct Target Ther"},{"key":"3894_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fcell.2020.00605","volume":"8","author":"AF Teixeira","year":"2020","unstructured":"Teixeira AF, Ten Dijke P, Zhu HJ. On-target anti-TGF-beta therapies are not succeeding in clinical cancer treatments: what are remaining challenges? Front Cell Dev Biol. 2020;8:605.","journal-title":"Front Cell Dev Biol"},{"key":"3894_CR12","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","volume":"17","author":"A Winer","year":"2018","unstructured":"Winer A, Adams S, Mignatti P. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. Mol Cancer Ther. 2018;17:1147\u201355.","journal-title":"Mol Cancer Ther"},{"key":"3894_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","volume":"124","author":"AI Riggio","year":"2021","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124:13\u201326.","journal-title":"Br J Cancer"},{"key":"3894_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00363-0","volume":"7","author":"I Mavrommati","year":"2021","unstructured":"Mavrommati I, Johnson F, Echeverria GV, Natrajan R. Subclonal heterogeneity and evolution in breast cancer. npj Breast Cancer. 2021;7:155.","journal-title":"npj Breast Cancer"},{"key":"3894_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41568-025-00814-x","volume":"25","author":"K Naxerova","year":"2025","unstructured":"Naxerova K. Evolutionary paths towards metastasis. Nat Rev Cancer. 2025;25:545\u201360.","journal-title":"Nat Rev Cancer"},{"key":"3894_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10555-023-10120-3","volume":"42","author":"M Janin","year":"2023","unstructured":"Janin M, Davalos V, Esteller M. Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics. Cancer Metastasis Rev. 2023;42:1071\u2013112.","journal-title":"Cancer Metastasis Rev"},{"key":"3894_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41416-020-01127-6","volume":"124","author":"SA Patel","year":"2021","unstructured":"Patel SA, Rodrigues P, Wesolowski L, Vanharanta S. Genomic control of metastasis. Br J Cancer. 2021;124:3\u201312.","journal-title":"Br J Cancer"},{"key":"3894_CR18","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s42003-021-02833-4","volume":"4","author":"S Namba","year":"2021","unstructured":"Namba S, Ueno T, Kojima S, Kobayashi K, Kawase K, Tanaka Y, et al. Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer. Commun Biol. 2021;4:1320.","journal-title":"Commun Biol"},{"key":"3894_CR19","doi-asserted-by":"publisher","first-page":"R331","DOI":"10.1016\/j.cub.2017.02.041","volume":"27","author":"SH Lo","year":"2017","unstructured":"Lo SH. Tensins. Curr Biol. 2017;27:R331\u2013R332.","journal-title":"Curr Biol"},{"key":"3894_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","volume":"14","author":"FJ Sulzmaier","year":"2014","unstructured":"Sulzmaier FJ, Jean C, Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer. 2014;14:598\u2013610.","journal-title":"Nat Rev Cancer"},{"key":"3894_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18:533\u201348.","journal-title":"Nat Rev Cancer"},{"key":"3894_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ccr.2009.07.031","volume":"16","author":"X Qian","year":"2009","unstructured":"Qian X, Li G, Vass WC, Papageorge A, Walker RC, Asnaghi L, et al. The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell. 2009;16:246\u201358.","journal-title":"Cancer Cell"},{"key":"3894_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/boc.201600053","volume":"109","author":"A Blangy","year":"2017","unstructured":"Blangy A. Tensins are versatile regulators of Rho GTPase signalling and cell adhesion. Biol Cell. 2017;109:115\u201326.","journal-title":"Biol Cell"},{"key":"3894_CR24","first-page":"1006","volume":"15","author":"J De Faria Poloni","year":"2018","unstructured":"De Faria Poloni J, Bonatto D. Influence of transcriptional variants on metastasis. RNA Biol. 2018;15:1006\u201324.","journal-title":"RNA Biol"},{"key":"3894_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436:518\u201324.","journal-title":"Nature"},{"key":"3894_CR26","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1093\/nar\/23.23.4907","volume":"23","author":"M Subramaniam","year":"1995","unstructured":"Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. Identification of a novel TGF-\u03b2-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res. 1995;23:4907\u201312.","journal-title":"Nucleic Acids Res"},{"key":"3894_CR27","doi-asserted-by":"crossref","unstructured":"Sulaiman A, McGarry S, Chilumula SC, Kandunuri R, Vinod V. Clinically translatable approaches of inhibiting TGF-beta to target cancer stem cells in TNBC. Biomedicines 2021;9:1386.","DOI":"10.3390\/biomedicines9101386"},{"key":"3894_CR28","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.4049\/jimmunol.161.7.3694","volume":"161","author":"T Suzuki","year":"1998","unstructured":"Suzuki T, Shoji S, Yamamoto K, Nada S, Okada M, Yamamoto T, et al. Essential roles of Lyn in fibronectin-mediated filamentous actin assembly and cell motility in mast cells. J Immunol. 1998;161:3694\u2013701.","journal-title":"J Immunol"},{"key":"3894_CR29","first-page":"252","volume":"119","author":"Y Pylayeva","year":"2009","unstructured":"Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest. 2009;119:252\u201366.","journal-title":"J Clin Invest"},{"key":"3894_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101872","volume":"6","author":"I Miranda","year":"2025","unstructured":"Miranda I, Jahan N, Shevde LA. The metastatic cascade through the lens of therapeutic inhibition. Cell Rep Med. 2025;6:101872.","journal-title":"Cell Rep Med"},{"key":"3894_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-023-00446-7","volume":"12","author":"X Tan","year":"2023","unstructured":"Tan X, Yan Y, Song B, Zhu S, Mei Q, Wu K. Focal adhesion kinase: from biological functions to therapeutic strategies. Exp Hematol Oncol. 2023;12:83.","journal-title":"Exp Hematol Oncol"},{"key":"3894_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.187.4.579","volume":"187","author":"B Levkau","year":"1998","unstructured":"Levkau B, Herren B, Koyama H, Ross R, Raines EW. Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J Exp Med. 1998;187:579\u201386.","journal-title":"J Exp Med"},{"key":"3894_CR33","doi-asserted-by":"publisher","first-page":"17102","DOI":"10.1074\/jbc.273.27.17102","volume":"273","author":"FG Gervais","year":"1998","unstructured":"Gervais FG, Thornberry NA, Ruffolo SC, Nicholson DW, Roy S. Caspases cleave focal adhesion kinase during apoptosis to generate a FRNK-like polypeptide. J Biol Chem. 1998;273:17102\u20138.","journal-title":"J Biol Chem"},{"key":"3894_CR34","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-07-6849","volume":"68","author":"D Barkan","year":"2008","unstructured":"Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 2008;68:6241\u201350.","journal-title":"Cancer Res"},{"key":"3894_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013;15:807\u201317.","journal-title":"Nat Cell Biol"},{"key":"3894_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41556-020-0474-3","volume":"22","author":"M Montagner","year":"2020","unstructured":"Montagner M, Bhome R, Hooper S, Chakravarty P, Qin X, Sufi J, et al. Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination. Nat Cell Biol. 2020;22:289\u201396.","journal-title":"Nat Cell Biol"},{"key":"3894_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJ Sleeboom","year":"2024","unstructured":"Sleeboom JJ, van Tienderen GS, Schenke-Layland K, van der Laan LJ, Khalil AA, Verstegen MM. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Trans Med. 2024;16:eadg3840.","journal-title":"Sci Trans Med"},{"key":"3894_CR38","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.molcel.2012.03.027","volume":"46","author":"G Thillainadesan","year":"2012","unstructured":"Thillainadesan G, Chitilian JM, Isovic M, Ablack JN, Mymryk JS, Tini M, et al. TGF-beta-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217\/CoREST complex. Mol Cell. 2012;46:636\u201349.","journal-title":"Mol Cell"},{"key":"3894_CR39","doi-asserted-by":"crossref","unstructured":"Bevant K, Desoteux M, Abdel Wahab AHA, Abdel Wahab SA, Metwally AM, Coulouarn C. DNA methylation of TGFbeta target genes: epigenetic control of TGFbeta functional duality in liver cancer. Cells 2021;10:2207.","DOI":"10.3390\/cells10092207"},{"key":"3894_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41576-024-00760-8","volume":"26","author":"ZD Smith","year":"2025","unstructured":"Smith ZD, Hetzel S, Meissner A. DNA methylation in mammalian development and disease. Nat Rev Genet. 2025;26:7\u201330.","journal-title":"Nat Rev Genet"},{"key":"3894_CR41","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1093\/nar\/gkab437","volume":"49","author":"E Batsche","year":"2021","unstructured":"Batsche E, Yi J, Mauger O, Kornobis E, Hopkins B, Hanmer-Lloyd C, et al. CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms. Nucleic Acids Res. 2021;49:6213\u201337.","journal-title":"Nucleic Acids Res"},{"key":"3894_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36967-2","volume":"14","author":"V Davalos","year":"2023","unstructured":"Davalos V, Lovell CD, Von Itter R, Dolgalev I, Agrawal P, Baptiste G, et al. An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma. Nat Commun. 2023;14:1867.","journal-title":"Nat Commun"},{"key":"3894_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","volume":"34","author":"A Kahles","year":"2018","unstructured":"Kahles A, Lehmann KV, Toussaint NC, Huser M, Stark SG, Sachsenberg T, et al. Comprehensive analysis of alternative splicing across tumors from 8,705 patients. Cancer Cell. 2018;34:211\u201324.e216.","journal-title":"Cancer Cell"},{"key":"3894_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fmolb.2018.00080","volume":"5","author":"E El Marabti","year":"2018","unstructured":"El Marabti E, Younis I. The cancer spliceome: reprograming of alternative splicing in cancer. Front Mol Biosci. 2018;5:80.","journal-title":"Front Mol Biosci"},{"key":"3894_CR45","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41586-022-05035-y","volume":"608","author":"DA Glinos","year":"2022","unstructured":"Glinos DA, Garborcauskas G, Hoffman P, Ehsan N, Jiang L, Gokden A, et al. Transcriptome variation in human tissues revealed by long-read sequencing. Nature. 2022;608:353\u20139.","journal-title":"Nature"},{"key":"3894_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-018-0085-0","volume":"15","author":"A Paschalis","year":"2018","unstructured":"Paschalis A, Sharp A, Welti JC, Neeb A, Raj GV, Luo J, et al. Alternative splicing in prostate cancer. Nat Rev Clin Oncol. 2018;15:663\u201375.","journal-title":"Nat Rev Clin Oncol"},{"key":"3894_CR47","doi-asserted-by":"crossref","unstructured":"Gadea G, Arsic N, Fernandes K, Diot A, Joruiz SM, Abdallah S, et al. TP53 drives invasion through expression of its Delta133p53beta variant. eLife 2016;5:e14734.","DOI":"10.7554\/eLife.14734"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03894-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03894-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03894-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:02:08Z","timestamp":1786399328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03894-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":47,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["3894"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03894-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All animal experiments were approved by the Committee on the Ethics of Animal Experiments of Chiba Cancer Center (Permit Number: 24-7, 24-8). No human participants were involved in this study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}